4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001395064-21-000231
10% owner sold 1,000,001 shares at an average $20.85 ($20,850,019)
- 10% owner acquired 228,696 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2021-11-04 | Option exercise | +228,696 | 1,100,001 | D | ||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2021-11-04 | Sale | −1 | $19.00 | $19 | 1,100,000 | D |
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2021-11-04 | Sale | −1,000,000 | $20.85 | $20,850,000 | 100,000 | D |
| Derivatives | |||||||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2021-11-04 | Option exercise · Warrants | −228,696 | 7,359,304 | D | ||
| Open-market sales · 1,000,001 sh · avg $20.85 · $20,850,019 | |||||||
Loading xslF345X03/wf-form4_163636942764423.xml…